Navigation Links
Ossur Acquires the U.S. Orthopaedics Company

Iceland-based Ossur hf., a global orthopaedics company, has acquired Innovation Sports, Inc., a U.S.-based ligament brace maker for $ 38.4 million.

The acquisition of Innovation Sports comes on the heels of Ossur's July 2005 acquisition// of Royce Medical in the U.S., and the December 2005 acquisition of IMP Holdings in the U.K. With these acquisitions, and its 2003 acquisition of Generation II, Ossur aspires to be one of the world's largest, and diversified companies in the braces and support market.

Ossur president & CEO Jon Sigurdsson said Innovation Sports would give Ossur a leading edge in ligament braces, the largest segment of the braces and support market, and accelerate Ossur's strategic initiative to advance in the orthopaedics market with improved operating efficiencies and other synergies.

Innovation Sports, based in Foothill Ranch, California, established in 1983, has 150 employees with the U.S. (50% sales), Canada (10%) and central Europe (40%) as its main markets. The company specializes in the manufacture of knee braces for the treatment of ligament injuries and rehabilitative uses, as well as protective braces for athletes. It also has product lines that address pain management and wrist braces, which are new to the Ossur product portfolio.

For the fiscal year ending 31 December 2005, Innovation Sports is expecting sales of $19 million and a normalized EBITDA margin of 19%. In connection with the acquisition, Ossur expects to incur approximately $3 million of integration and restructuring expenses in 2006 fully expensed in Q1, but projects that these efforts will yield approximately $4 million of annual cost savings beginning in 2007.

In connection with the acquisition, additional funding of $40 million has been provided by Kaupting bank hf.

Ossur is a trusted and global leader in the development, manufacturing, distribution, sales and marketing of braces and support products and prosthetic s. Headquartered in Reykjavik, Iceland, the company has operations and a distribution network throughout the world.
'"/>




Related medicine news :

1. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
2. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
3. Premier Army Hospital Acquires PET-CT Scanner
4. Indoco Remedies Acquires La Nova Chem
5. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
6. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
7. Apollos Global Arm Acquires US-based Firm
8. ‘Obesity’ Acquires Permanent Resident Status in the US
9. Indias Wockhardt Acquires Irish Firm
10. Battle against Gum Disease Acquires new Weapon
11. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... North Hollywood, CA (PRWEB) , ... March 29, 2017 , ... ... and Northridge , is now offering laser dental treatments. Dental lasers are safe ... treatments. Laser dentistry expands patients’ options and can improve the overall quality of care. ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who manage ... Intercontinental Time Square, New York. , The program will be led by ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft Cloud expert, ... in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is ... Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)...  Glenmark Pharmaceuticals, a global pharmaceutical company, today ... fixed-dose combination of mometasone furoate (25 mcg) and ... nasal spray being studied for the treatment of ... recently completed Phase 3 trial assessing the efficacy ... mometasone, olopatadine or placebo. "We continue ...
(Date:3/29/2017)... 29, 2017 Transparency Market ... provides an exhaustive study of the U.S. substance abuse ... companies are functional in this market at present, ... leading companies, such as GlaxoSmithKline Plc., Pfizer Inc., ... on various marketing strategies to increase their visibility, ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 2.87% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: